Skip to main content
OpenTrials

Clinical trial condition

Otorhinolaryngologic Neoplasms

Explore clinical trials studying Otorhinolaryngologic Neoplasms. Study availability and eligibility vary by location and protocol.

929 public trials 271 recruiting studies
Refine in advanced search Browse all conditions

Otorhinolaryngologic Neoplasms trial results

Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 229 locations
View Trial Details
Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

NCT07195734

Conditions
Carcinoma, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +33 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sutter Medical Center Sacramento Sacramento, California, United States
View all 110 locations
View Trial Details
Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

NCT06589804

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +38 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Fremont - Rideout Cancer Center Marysville, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • UCHealth Memorial Hospital Central Colorado Springs, Colorado, United States
View all 199 locations
View Trial Details
Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

NCT06064097

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +14 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 86 locations
View Trial Details
Recruiting

StableEyes With Active Neurofeedback

NCT05622344

Conditions
Cranial Nerve Diseases, Cranial Nerve Neoplasms, Ear Diseases, +26 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Naval Medical Research Unit Dayton, Ohio, United States
View Trial Details
Recruiting

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

NCT06980038

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +41 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Ochsner Medical Center Jefferson New Orleans, Louisiana, United States
View Trial Details
Recruiting

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

NCT07038343

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +34 more
Locations
  • Avenzo Therapeutics Recruiting Site Gilbert, Arizona, United States
  • Avenzo Therapeutics Recruiting Site Los Angeles, California, United States
  • Avenzo Therapeutics Recruiting Site Denver, Colorado, United States
  • Avenzo Therapeutics Recruiting Site New Haven, Connecticut, United States
View all 19 locations
View Trial Details
Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

NCT06029270

Conditions
Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +14 more
Locations
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
  • Kaiser Permanente Fresno Orchard Plaza Fresno, California, United States
  • Kaiser Permanente-Fresno Fresno, California, United States
View all 88 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

NCT07156227

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +48 more
Locations
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View Trial Details
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University School of Medicine Indianopolis, Indiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details

Related conditions